// App-Quantinova.ai

12929 : Neointimal Coverage of Everolimus-Eluting Stent Compared to Sirolimus-Eluting Stent: Optical Coherence Tomography Subanalysis from the RESET Trial

Researchers

Presenter

  • Takashi Kubo

Principal Investigators

  • Yoshihisa Nakagawa

  • Keiichi Igarashi

  • Kengo Tanabe

  • Yoshihiro Morino

  • Masashi Iwabuchi

  • Kazuo Kimura

  • Ken Kozuma

  • Takeshi Kimura

Medical Centers

  • Tokai Univ Hosp, Isehara, Japan

  • Kyoto University Graduate School of Medicine, Kyoto, Japan

  • Yokohama City University Medical Center, Yokohama City, Japan

  • Tenri Hospital, Tenri, Japan

  • Hokkaido Social Insurance Hospital, Sapporo, Japan

  • Mitsui Memorial Hospital, Tokyo, Japan

  • Teikyo Univ Hosp, Tokyo, Japan

  • Kokura memorial hospital, Kitakyusyu, Japan

  • Wakayama Medical University, Wakayama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary Artery Disease

  • Cardiac arrest

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved